MW-150 hydrochloride
Modify Date: 2024-01-11 10:22:56
MW-150 hydrochloride structure
|
Common Name | MW-150 hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1923773-01-6 | Molecular Weight | 417.93 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H24ClN5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MW-150 hydrochlorideMW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a selective inhibitor of p38αMAPK isoform with a ki of 101 nM[1]. |
| Name | MW-150 hydrochloride |
|---|
| Description | MW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a selective inhibitor of p38αMAPK isoform with a ki of 101 nM[1]. |
|---|---|
| Related Catalog | |
| Target |
p38α:101 nM (Ki) |
| In Vitro | MW-150 hydrochloride inhibits in a concentration-dependent manner the ability of the endogenous p38αMAPK to phosphorylate an endogenous substrate MK2 in activated glia[1]. MW-150 hydrochloride blocks in a concentration-dependent manner the increased IL-1β production by activated glia. The IC50 values are 332 nM and 936 nM for MK2 and IL-1β, respectively[1]. |
| In Vivo | MW-150 hydrochloride (2.5 mg/kg; oral daily for 3−4 months) improves the APP/PS1 transgenic (Tg) mice performance in radial arm water maze (RAWM) and contextual fear conditioning tests[1]. MW-150 hydrochloride (2.5 mg/kg; given i.p.; daily for 14 days) treatment in APPNLh/NLh × PSP264L/P264L knock-in mouse (with no overexpression of the amyloid precursor protein) exhibits RAWM behavior indistinguishable from WT mice[1]. Animal Model: APP/PS1 transgenic (Tg) mouse (overexpresses amyloid-beta) [1] Dosage: 2.5 mg/kg Administration: Oral daily; 3-4 months (until cognitive impairment is present) Result: Improved the Tg mice performance in both cognitive tests. |
| References |
| Molecular Formula | C24H24ClN5 |
|---|---|
| Molecular Weight | 417.93 |